Biomarker databases

Biomarker database There are several databases that are used to track biomarkers. The important thing to keep in mind is that the biomarker may be biological entity like a protein, lipid or DNA/RNA fragment but they can also be a group of cells – for example Tumor infiltrating cells or, physiological test, clinical outcome measure even an online test. The biomarker databases usually add a list of publications and some other resources such as usage in clinical trials or review by FDA. These database useful if the main purpose is to search through a list and sort out the important ones in an exploratory study. However, the critical test for any biomarker is to determine if it indeed follows the disease and/or the drug being developed to modify the disease. Here is a list of some of those Biomarker databases, with a very short review on each.

 

Public domain:

NCI has their own database that is cancer specific and has comprehensive information. https://edrn.nci.nih.gov/biomarkers#b_start=0

Online Mendelian Inheritance in Man (OMIM) for gene disorders: Not quite a biomarker database but possible to find immense amount of information quickly. http://www.omim.org/

Human Metabolome database: This is comprehensive and searchable if you are looking for a metabolite for a specific disease. http://www.hmdb.ca/

Disease related biomarkers from a publication that needs some understanding to fully utilize the resources. http://ibi.imim.es/biomarkers/

US EPA has a database that can be downloaded by anyone but has not been updated since 2004. https://cfpub.epa.gov/ncea/risk/recordisplay.cfm?deid=85844

 

Disease specific:

To find specific disease type through an ontology use this portal http://medportal.bmicc.cn/ontologies/DOID

 

Or use this for details on human diseases: http://www.malacards.org/

Urinary protein biomarker. This is quite comprehensive and searchable and worth a look. http://59.108.16.249/biomarker/web/indexdb

Stroke biomarkers. Good classification of some areas within stroke and can lead to interesting areas to click to explore new biomarkers. http://stroke-biomarkers.com/

Alzhiemer’s research https://www.alzforum.org/alzbiomarker

 

 

Sampling of some Commercial ones:

Charles River have created an accessible database for some disorders that is great for exploring new areas. https://www.criver.com/resources/biomarker-database

BiomarkerBase by Amplion: They promise a lot but without the ability to test ride the database. https://www.biomarkerbase.com/

Global online biomarker database (Gobiom) by GVKBio claims to be the biggest one and some of their work goes through significant amounts of data to sort out characteristic of specific biomarkers. https://gobiomdb.com/login.jsp

 

 

This is not a comprehensive list and needs work to build up a database of databases.

Similar Posts

  • |

    Bile duct cancer

    Bile duct cancer or cholangiocarcinoma, (CCA) is a rare cancer with an incidence of ~3 cases per 100,000 with 10,000 new case diagnosed annually. It is about 10-20% of liver cancers. Interestingly, in Thailand, and some south east asian countries, the incidence is nearly 10 fold higher due to liver fluke infections (Opisthorchis viverrini and…

  • |

    Bisphenol A

    There is lot of information on BPA on wikipedia that talks about its use in plastics especially polycarbonates that are used in water bottle manufacturing. Polycarbonate bottles are transparent and can contain 90% BPA by mass It is not a plasticizer. The concern for its use comes from its effect as a weak xenoestrogen disrupting…

  • Filtering bacteria

    Multi Drug resistance to bacteria is a problem since bacteria continue dividing in blood causing sepsis that cannot be controlled by antibiotics and ultimately causing death. There have been multiple methods that have been proposed. A unique method has been published in Nature that incorporates “filtering” blood to remove the bacteria.Blood flows very rapidly through…

  • Considerations for analysis of clinical samples

    When diagnostic tests are implemented in clinical studies there are multiple considerations beyond just the assay and the analyte that are not generally considered but are important. For example: Sample collection, preparation and transport Standards need to be specified for pre-analysis that would specify the conditions needed even before the analysis are done. Selection of…

  • | | |

    Biotech companies

    Small Biotechs: Diagonal Tx: Clustering antibodies that mimic the action of the ligand and bypass the need for the ligand and receptor. This mutation that is created makes standard AI models not useful and so need a new method. This restores new ALK1 signaling in Hereditary Hemorrhagic Telangiectasia. It also treates LoF mutations in ALK1…

  • Liquid biopsy guidelines

    A term that was created in 2010 called “liquid biopsy” became the standard for much of the screening of cancer that is done using blood to check for cancer cells though the NCI definition is specific for cancer and used to include its applications in detecting cancer and determining therapeutic efficacy : https://www.cancer.gov/publications/dictionaries/cancer-terms/def/liquid-biopsy The first…